drugset / Trial / NCT00220675

Erythropoietin Spinal Cord Compression Randomized Trial

NCT00220675

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine whether erythropoietin, steroids and radiotherapy is safe and feasible to administer to patients with malignant spinal cord compression.

Timeline

Start
2005-08
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic Intravenous